Circular RNAs as potential therapeutics and novel biomarkers for heart failure

Abstract

Heart failure (HF) is a type of chronic pathological remodeling in which the heart fails to efficiently supply an adequate amount of blood to fulfill the body’s requirements. Circular RNAs (circRNAs) are recognized as specific types of long noncoding RNAs that are involved in the regulation of the pathogenesis of cardiovascular diseases, including cardiac remodeling and HF. In this review, knowledge about the origin, characteristics, and function of circRNAs is summarized. The regulatory function of circRNAs in cardiac remodeling mechanisms, including cell death, cardiac hypertrophy, fibrosis and mitochondrial metabolism, is reviewed. Finally, future directions for investigating the diagnostic and pharmacological potential of circRNAs in HF are proposed.

Keywords

Cardiac remodeling / heart failure / circular RNA / cardiac hypertrophy / cardiac fibrosis / biomarker / therapeutic target

References

[1] Bertero E.Metabolic remodelling in heart failure.Nat Rev Cardiol2018;15:457-70

[2] Timmis A,Gale CP.European society of cardiology: cardiovascular disease statistics 2019.Eur Heart J2020;41:12-85

[3] Perrino C.Intermittent pressure overload triggers hypertrophy-independent cardiac dysfunction and vascular rarefaction.J Clin Investig2006;116:1547-60 PMCID:PMC1464895

[4] Frantz S,Schulz-Menger J,Bauersachs J.Left ventricular remodelling post-myocardial infarction: pathophysiology, imaging, and novel therapies.Eur Heart J2022;43:2549-61 PMCID:PMC9336586

[5] Schirone L,D’ambrosio L.An overview of the molecular mechanisms associated with myocardial ischemic injury: state of the art and translational perspectives.Cells2022;11:1165 PMCID:PMC8998015

[6] Micheel J,Wollny D.Advances in non-coding RNA sequencing.Noncoding RNA2021;7:70 PMCID:PMC8628893

[7] Gao J,Wang J,Li P.The role and molecular mechanism of non-coding RNAs in pathological cardiac remodeling.Int J Mol Sci2017;18:608 PMCID:PMC5372624

[8] Jha S,Kumaran K,Aruljothi KN.Long non-coding RNAs (lncRNAs) in heart failure: a comprehensive review.Noncoding RNA2023;10:3 PMCID:PMC10801533

[9] Shen S,Bei Y,Li X.Long non-coding RNAs in cardiac remodeling.Cell Physiol Biochem2017;41:1830-7

[10] Salzman J,Wang PL,Brown PO.Circular RNAs are the predominant transcript isoform from hundreds of human genes in diverse cell types.PLoS ONE2012;7:e30733 PMCID:PMC3270023

[11] Zhang C,Wu Z.Rapid development of targeting circRNAs in cardiovascular diseases.Mol Ther Nucleic Acids2020;21:568-76 PMCID:PMC7390851

[12] Ding C.Insights into circular RNAs: biogenesis, function and their regulatory roles in cardiovascular disease.J Cell Mol Med2023;27:1299-314 PMCID:PMC10183707

[13] Joaquim VHA,Fernandes T.Circular RNAs as a diagnostic and therapeutic target in cardiovascular diseases.Int J Mol Sci2023;24:2125 PMCID:PMC9916891

[14] Wang X.Features and biomedical relevance of circular RNA biogenesis.Trends Genet2026;42:282-94

[15] Hansen TB,Clausen BH.Natural RNA circles function as efficient microRNA sponges.Nature2013;495:384-8

[16] Zhou W,Liu J,Ju H.Circular RNA: metabolism, functions and interactions with proteins.Mol Cancer2020;19:172 PMCID:PMC7734744

[17] Hwang HJ.Molecular mechanisms of circular RNA translation.Exp Mol Med2024;56:1272-80 PMCID:PMC11263353

[18] Capirossi G,Tremoli E,Roncarati R.Circular RNAs in cardiovascular physiopathology: from molecular mechanisms to therapeutic opportunities.Int J Mol Sci2025;26:9725 PMCID:PMC12525237

[19] Lee Y.Role of apoptosis in cardiovascular disease.Apoptosis2009;14:536-48

[20] Geng H,Su Y.The circular RNA Cdr1as promotes myocardial infarction by mediating the regulation of miR-7a on its target genes expression.PLoS ONE2016;11:e0151753 PMCID:PMC4801407

[21] Wang L,Wang J.Downregulation of circ-ZNF609 promotes heart repair by modulating RNA N⁶-methyladenosine-modified Yap expression.Research2022;2022:9825916 PMCID:PMC9012977

[22] Yu P,Xu G.RNA m6A-regulated circ-ZNF609 suppression ameliorates doxorubicin-induced cardiotoxicity by upregulating FTO.JACC Basic Transl Sci2023;8:677-98 PMCID:PMC10322883

[23] Zhu Y,Sun L.Overexpression of circRNA SNRK targets miR-103-3p to reduce apoptosis and promote cardiac repair through GSK3β/β-catenin pathway in rats with myocardial infarction.Cell Death Discov2021;7:84 PMCID:PMC8055694

[24] Yuan Q,Yang F.CircRNA DICAR as a novel endogenous regulator for diabetic cardiomyopathy and diabetic pyroptosis of cardiomyocytes.Sig Transduct Target Ther2023;8:99 PMCID:PMC9992392

[25] Wang D,Wang Y,Tang H.Circ_0001206 regulates miR-665/CRKL axis to alleviate hypoxia/reoxygenation-induced cardiomyocyte injury in myocardial infarction.ESC Heart Fail2022;9:998-1007 PMCID:PMC8934946

[26] Li Y,Xia J,Xi Y.EIF4A3-induced circ-BNIP3 aggravated hypoxia-induced injury of H9c2 cells by targeting miR-27a-3p/BNIP3.Mol Ther Nucleic Acids2020;19:533-45 PMCID:PMC6951839

[27] Li D,Mao C.Circular RNA Fbxl5 regulates cardiomyocyte apoptosis during ischemia reperfusion injury via sponging microRNA-146a.J Inflamm Res2022;15:2539-50 PMCID:PMC9037744

[28] Wang L,Feng X.Exercise-induced circular RNA circUtrn is required for cardiac physiological hypertrophy and prevents myocardial ischaemia-reperfusion injury.Cardiovasc Res2023;119:2638-52

[29] Gao X,Zhang Y.The circRNA CNEACR regulates necroptosis of cardiomyocytes through Foxa2 suppression.Cell Death Differ2021;29:527-39 PMCID:PMC8901615

[30] Ju J,Zhao X.Circular RNA FEACR inhibits ferroptosis and alleviates myocardial ischemia/reperfusion injury by interacting with NAMPT.J Biomed Sci2023;30:45 PMCID:PMC10304620

[31] Lu D,Xiao K.A circular RNA derived from the insulin receptor locus protects against doxorubicin-induced cardiotoxicity.Eur Heart J2022;43:4496-511 PMCID:PMC9637424

[32] Shen M,Li L,Liu G.CircMAP3K5 promotes cardiomyocyte apoptosis in diabetic cardiomyopathy by regulating miR‐22‐3p/DAPK2 Axis.J Diabetes2023;16:e13471

[33] Pitoulis FG.Heart plasticity in response to pressure- and volume-overload: a review of findings in compensated and decompensated phenotypes.Front Physiol2020;11:92 PMCID:PMC7031419

[34] Shimizu I.Physiological and pathological cardiac hypertrophy.J Mol Cell Cardiol2016;97:245-62

[35] Li M,Fang X.Novel truncated peptide derived from circCDYL exacerbates cardiac hypertrophy.Circ Res2025;136:e94-112

[36] Pan W,Chatterjee S.A circular RNA derived from the ryanodine receptor 2 locus controls cardiac hypertrophy and calcium handling.Cell Mol Life Sci2025;82:359 PMCID:PMC12540953

[37] Yang M,Wang L.Circ_0001052 promotes cardiac hypertrophy via elevating Hipk3.Aging2023;15:204521 PMCID:PMC10008499

[38] Wang K,Liu F.A circular RNA protects the heart from pathological hypertrophy and heart failure by targeting miR-223.Eur Heart J2016;37:2602-11

[39] Xu Q,Zhu R.NSD2 promotes pressure overload-induced cardiac hypertrophy via activating circCmiss1/TfR1/ferroptosis signaling.Life Sci2023;328:121873

[40] Pan J,Guo G.Circ_nuclear factor I X (circNfix) attenuates pressure overload-induced cardiac hypertrophy via regulating miR-145-5p/ATF3 axis.Bioengineered2021;12:5373-85 PMCID:PMC8806771

[41] Li H,Fang X.Circular RNA circRNA_000203 aggravates cardiac hypertrophy via suppressing miR-26b-5p and miR-140-3p binding to Gata4.Cardiovasc Res2020;116:1323-34

[42] Lin X,Zhang W,Lu Q.Circular RNA circ_0001006 aggravates cardiac hypertrophy via miR-214-3p/PAK6 axis.Aging2022;14:2210-20 PMCID:PMC8954976

[43] Miličić D,Fabijanović D.Microcirculation and heart failure.Curr Pharm Des2018;24:2954-9

[44] Vancheri F,Vancheri S.Coronary microvascular dysfunction.J Clin Med2020;9:2880 PMCID:PMC7563453

[45] Si X,Wei G.circRNA Hipk3 induces cardiac regeneration after myocardial infarction in mice by binding to notch1 and miR-133a.Mol Ther Nucleic Acids2020;21:636-55 PMCID:PMC7393325

[46] Li B,Guo T.Statins improve cardiac endothelial function to prevent heart failure with preserved ejection fraction through upregulating circRNA-RBCK1.Nat Commun2024;15:2953 PMCID:PMC10997751

[47] Conn SJ,Toubia J.The RNA binding protein quaking regulates formation of circRNAs.Cell2015;160:1125-34

[48] Liao J,Wang Y.Deep sequencing reveals a global reprogramming of lncRNA transcriptome during EMT.Biochim Biophys Acta Mol Cell Res2017;1864:1703-13

[49] Madè A,Garcia-Manteiga JM.circRNA-miRNA-mRNA deregulated network in ischemic heart failure patients.Cells2023;12:2578 PMCID:PMC10648415

[50] Yamada Y,Nakano K.Cardiac reprogramming and Gata4 overexpression reduce fibrosis and improve diastolic dysfunction in heart failure with preserved ejection fraction.Circulation2025;151:379-95

[51] Wu N,Du WW.YAP circular RNA, circYap, attenuates cardiac fibrosis via binding with tropomyosin-4 and gamma-actin decreasing actin polymerization.Mol Ther2021;29:1138-50

[52] Du WW,Yuan H.A novel protein NAB1‐356 encoded by circRNA circNAB1 mitigates atrial fibrillation by reducing inflammation and fibrosis.Adv Sci2025;12:2411959 PMCID:PMC12120700

[53] Zhang L,Zhang W.CircCAMTA1 facilitates atrial fibrosis by regulating the miR-214-3p/TGFBR1 axis in atrial fibrillation.J Mol Histol2022;54:55-65

[54] Du WW,Yang W.A neuroligin isoform translated by circNlgn contributes to cardiac remodeling.Circ Res2021;129:568-82

[55] Mei S,Zhou L.CircSMAD3 represses SMAD3 phosphorylation and ameliorates cardiac remodeling by recruiting YBX1.iScience2024;27:111305 PMCID:PMC11570450

[56] Jung M,Sansonetti M.Macrophage-specific circular RNA circHIPK2, inflammation, and fibrosis after myocardial infarction.Eur Heart J2026;47:2831-47 PMCID:PMC13247189

[57] Jeong A,Kook T.Circular RNA circSMAD4 regulates cardiac fibrosis by targeting miR-671-5p and FGFR2 in cardiac fibroblasts.Mol Ther Nucleic Acids2023;34:102071 PMCID:PMC10690640

[58] Wang Y,Zhang L,Liu N.A novel identified circular RNA, circSnap47, promotes heart failure progression via regulation of miR-223-3p/MAPK axis.Mol Cell Biochem2022;478:459-69

[59] Schmidt A,Groß S.Circular RNA circIGF1R controls cardiac fibroblast proliferation through regulation of carbohydrate metabolism.Sci Rep2025;15:20331 PMCID:PMC12205068

[60] Bibi A,Greco S.Circular PVT1 promotes cardiac fibroblast activation interacting with miR-30a-5p and miR-125b-5p.Cell Death Dis2025;16:325 PMCID:PMC12012019

[61] Yan J,Chen Q.CircMap4k2 reactivated by aneurysm plication alleviates residual cardiac remodeling after SVR by enhancing cardiomyocyte proliferation in post-MI mice.J Adv Res2024;65:227-38 PMCID:PMC11518968

[62] Ma GB,Zhan FJ.Circ_0002295 facilitated myocardial fibrosis progression through the miR‐1287/CXCR2 axis.Clin Exp Pharmacol Physiol2023;50:944-53

[63] Wang Y,Zhao R.CircUbe3a from M2 macrophage-derived small extracellular vesicles mediates myocardial fibrosis after acute myocardial infarction.Theranostics2021;11:6315-33 PMCID:PMC8120198

[64] Jiang Y,Zhang B.A novel feedback loop: CELF1/circ-CELF1/BRPF3/KAT7 in cardiac fibrosis.Acta Pharm Sin B2025;15:5192-211 PMCID:PMC12541625

[65] Guo J,Huang Z.Suppression of the inhibitory effect of circ_0036176-translated Myo9a-208 on cardiac fibroblast proliferation by miR-218-5p.J Cardiovasc Transl Res2022;15:548-59

[66] Pang P,Wu H.The circular RNA circHelz enhances cardiac fibrosis by facilitating the nuclear translocation of YAP1.Transl Res2023;257:30-42

[67] Sun LY,Ge XM,Wang CM.Circ_LAS1L regulates cardiac fibroblast activation, growth, and migration through miR‐125b/SFRP5 pathway.Cell Biochem Funct2020;38:443-50

[68] Lopaschuk GD,Tian R,Abel ED.Cardiac energy metabolism in heart failure.Circ Res2021;128:1487-513 PMCID:PMC8136750

[69] Sun Q,Wong N.Advances in myocardial energy metabolism: metabolic remodelling in heart failure and beyond.Cardiovasc Res2024;120:1996-2016 PMCID:PMC11646102

[70] Gibb AA.Metabolic coordination of physiological and pathological cardiac remodeling.Circ Res2018;123:107-28 PMCID:PMC6023588

[71] Zheng H,Wei G.CircRNA Samd4 induces cardiac repair after myocardial infarction by blocking mitochondria-derived ROS output.Mol Ther2022;30:3477-98 PMCID:PMC9637749

[72] Li F,Li X.A new protein isoform encoded by human circular RNA circSLC8a1 contributes to cardiac remodelling.Cardiovasc Res2025;121:882-99 PMCID:PMC12160813

[73] Chen X,Zhao X.PYRCR alleviates myocardial ischemia/reperfusion injury in mice via inhibiting DRG2-mediated cardiomyocyte pyroptosis.Acta Pharmacol Sin2025;46:3204-16 PMCID:PMC12644509

[74] Ni X,Bao Y.Circ_005077 accelerates myocardial lipotoxicity induced by high-fat diet via CyPA/p47PHOX mediated ferroptosis.Cardiovasc Diabetol2024;23:129 PMCID:PMC11020354

[75] Wang Z,Deng Y.Negative feedback of SNRK to circ-SNRK regulates cardiac function post-myocardial infarction.Cell Death Differ2021;29:709-21 PMCID:PMC8989981

[76] Juni RP,Bink DI.COVID19 impairs cardiac function via endothelial H19 and IL6 signaling.Circ Res2023;132:648-51 PMCID:PMC9977263

[77] Robinson EL,Brittan M.Dissecting the transcriptome in cardiovascular disease.Cardiovasc Res2022;118:1004-19 PMCID:PMC8930073

[78] Zhou Q,Yao J.Diagnosis of acute myocardial infarction using a combination of circulating circular RNA cZNF292 and clinical information based on machine learning.MedComm2023;4:e299 PMCID:PMC10264944

[79] Sun Y,Lv Y.Circular RNA expression profiles in plasma from patients with heart failure related to platelet activity.Biomolecules2020;10:187 PMCID:PMC7072558

[80] Chen C,Huang Q.The circular RNA CDR1as regulates the proliferation and apoptosis of human cardiomyocytes through the miR-135a/HMOX1 and miR-135b/HMOX1 axes.Genet Test Mol Biomarkers2020;24:537-48

[81] He S,Zhang J,Zhao L.Genome-wide screening for circRNAs in epicardial adipose tissue of heart failure patients with preserved ejection fraction.Am J Transl Res2023;15:4610-9 PMCID:PMC10408519

[82] Costa MC,Mangas A.Circulating circRNA as biomarkers for dilated cardiomyopathy etiology.J Mol Med2021;99:1711-25 PMCID:PMC8599237

[83] Han J,Hu L.Circular RNA-expression profiling reveals a potential role of Hsa_circ_0097435 in heart failure via sponging multiple MicroRNAs.Front Genet2020;11:212 PMCID:PMC7076158

[84] Yan H,Wang C.Downregulation of autophagy-related circular RNA (ACR) is correlated with poor survival of patients with chronic heart failure.Bioengineered2022;13:13141-9 PMCID:PMC9276015

[85] Feng Y,Cheng H.Knockdown circ_0040414 inhibits inflammation, apoptosis and promotes the proliferation of cardiomyocytes via miR‐186‐5p/PTEN/AKT axis in chronic heart failure.Cell Biol Int2021;45:2304-15

[86] Xu S,Tan X.Differential expression spectrum of circRNA in plasma exosomes in dilated cardiomyopathy with heart failure.J Cell Mol Med2024;28:e70258 PMCID:PMC11668728

[87] Collado A,Tengbom J,Pernow J.Extracellular vesicles and their non‐coding RNA cargos: emerging players in cardiovascular disease.J Physiol2022;601:4989-5009

[88] Ge X,Zhuang R.Circular RNA expression alterations in extracellular vesicles isolated from murine heart post ischemia/reperfusion injury.Int J Cardiol2019;296:136-40

[89] Liu X,Han R.Circulating exosomal CircRNAs as diagnostic biomarkers for chronic coronary syndrome.Metabolites2023;13:1066 PMCID:PMC10608616

[90] Liu X,Yuan W.Exosomal CircRNAs in circulation serve as diagnostic biomarkers for acute myocardial infarction.Front Biosci2024;29:149

[91] Yang D,Zhang H.Progress, opportunity, and perspective on exosome isolation - efforts for efficient exosome-based theranostics.Theranostics2020;10:3684-707 PMCID:PMC7069071

[92] Li S,Xue W.Screening for functional circular RNAs using the CRISPR-Cas13 system.Nat Methods2020;18:51-9

[93] Holdt LM,Teupser D.Circular RNAs as therapeutic agents and targets.Front Physiol2018;9:1262 PMCID:PMC6189416

[94] Lavenniah A,Li YP.Engineered circular RNA sponges act as miRNA inhibitors to attenuate pressure overload-induced cardiac hypertrophy.Mol Ther2020;28:1506-17 PMCID:PMC7264434

[95] Wu H,Gao Y.circSP199a, a circularized RNA sponge targeting miR-199a-5p and -3p, mitigates mouse cardiac hypertrophy and fibrosis.Acta Pharmacol Sin2025;47:86-102 PMCID:PMC12764996

[96] Wesselhoeft RA,Anderson DG.Engineering circular RNA for potent and stable translation in eukaryotic cells.Nat Commun2018;9:2629 PMCID:PMC6035260

[97] Inglut CT,Kuruppu T.Immunological and toxicological considerations for the design of liposomes.Nanomaterials2020;10:190 PMCID:PMC7074910

[98] Tenchov R,Curtze AE.Lipid nanoparticles-from liposomes to mRNA vaccine delivery, a landscape of research diversity and advancement.ACS Nano2021;15:16982-7015

[99] Niu D,Lian J.Circular RNA vaccine in disease prevention and treatment.Sig Transduct Target Ther2023;8:341 PMCID:PMC10493228

[100] Qiu M,Bloomer H.Developing biodegradable lipid nanoparticles for intracellular mRNA delivery and genome editing.Acc Chem Res2021;54:4001-11

[101] Lopresti ST,Chaudhary N.The replacement of helper lipids with charged alternatives in lipid nanoparticles facilitates targeted mRNA delivery to the spleen and lungs.J Controlled Release2022;345:819-31 PMCID:PMC9447088